(Updates with prior price target, analyst averages.)
Biohaven (BHVN) has an average rating of overweight and mean price target of $21.56, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)